Effect of the Imera Cultivar Carob in Postprandial Glycemia (IMERACAROBGLUC)

April 4, 2025 updated by: Andriana C. Kaliora, Harokopio University

Impact of the Imera Carob Cultivar in Postprandial Glycemia

An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response

Study Overview

Status

Completed

Detailed Description

This is an acute randomized crossover study on the effect of an Imera cultivar carob beverage on postprandial glycemic response in healthy individuals as opposed to sucrose-based beverage containing sugar in alike concentration

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Attica
      • Kallithea, Attica, Greece, 17676
        • Department of Nutrition and Dietetics, HarokopioUniversity of Athens

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • healthy male adults of normal body fat mass

Exclusion Criteria:

  • obesity (according to body fat mass), type 1 Diabetes, hypertension and other cardiovascular diseases, thyroid disorder, liver, kidney, gastrointestinal disease, mental illness, use of nutraceutical supplements or natural products for weight loss and the background of dietitian/nutritionist.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Carob beverage
The participants consumed a carob beverage prepared with 30 g of Imera cultivar carob powder dissolved in water
The participants consumed a carob beverage made with 30gr of Imera carob cultivar powder in water
Active Comparator: Sucrose beverage
The participants consumed a sucrose beverage made containing 14 g of sugar, matched to the sugar concentration of the experimental beverage
The participants consumed a sucrose beverage made with 14gr of sugar in alike concentration with sugars in the experimental beverage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial glucose
Time Frame: 3 hours
Changes in glucose levels after the consumption of the beverage
3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial insulin
Time Frame: 3 hours
Changes in insulin levels after consuming the beverage
3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2024

Primary Completion (Actual)

May 31, 2024

Study Completion (Actual)

September 30, 2024

Study Registration Dates

First Submitted

March 26, 2025

First Submitted That Met QC Criteria

March 26, 2025

First Posted (Actual)

April 2, 2025

Study Record Updates

Last Update Posted (Actual)

April 6, 2025

Last Update Submitted That Met QC Criteria

April 4, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CAROB_GLUCOSE_147
  • 016713 (Other Grant/Funding Number: Hellenic Foundation for Research and Innovation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postprandial Glucose Regulation

Clinical Trials on Carob beverage

Subscribe